This week, senior BBC News presenter Maryam Moshiri confirmed she continues to undergo treatment for an incurable form of blood cancer after a two‑year battle that has tested both her body and her spirit. Despite her demanding schedule—including high‑profile coverage of the coronation of King Charles III, the papal conclave, and the Iran conflict—the 49‑year‑old presenter remains determined to keep delivering news, though she openly acknowledges that the physical demands of the disease take a heavy toll. Her diagnosis came in November 2024, leaving her to balance a career that spans nearly two decades of fronting programmes such as The World Today with the relentless cycle of chemotherapy and blood removal required for management.
Understanding Polycythaemia Vera and Its Clinical Impact
Polycythaemia vera (PV) is a rare myeloproliferative disorder that arises from abnormal growth of stem cells in the bone marrow, prompting excessive production of red blood cells. The result is a thickened blood plasma that increases viscosity, raising the risk of clotting and stroke. For Moshiri, the condition meant sleepless nights as doctors prescribed regular phlebotomy to draw off excess red cells and restore normal blood volume. Over the past eighteen months, she has faced episodes of dizziness, headaches, and profound weakness that lingered long after treatments concluded. As one colleague noted, the diagnosis did not arrive suddenly but rather unfolded gradually, a slow erosion of energy that eventually forced her into hospitalisation and prolonged recovery periods.
The Double Burden of On‑Air Responsibility and Chronic Fatigue
Moshiri’s ten‑plus‑year tenure at the public broadcaster stretches back to 2003, granting her a reputation for gravitas and reliability that audiences recognise instantly. From breaking reports on geopolitical crises to hosting cultural premieres, she has become synonymous with the timeless delivery of news. Yet the intersection of celebrity and chronic illness creates a unique strain. During the coronation festivities and the recent death of Pope Francis, she was required to maintain a presence on air for fourteen‑hour shifts, often without adequate downtime. The physiological reality is stark: her white‑blood counts demand frequent interventions, each session draining reserves that should be reserved for sleep and recovery. Even during brief respites, the mental acuity needed to analyse rapid developments collides with the bone‑deep exhaustion caused by a condition that, while treatable in acute phases, offers no cure for the underlying cellular malfunction.
“I love what I do,” Moshiri told The Times, “and I refuse to let the disease dictate the terms of my contribution.” The irony is palpable: she works tirelessly to inform the world while battling a condition that makes every shift feel like a marathon against invisible odds. Her mother once asked why she could not simply step away when the fatigue became unbearable, and Moshiri’s response captured the resilience that defines her journey—a blend of professional pride and personal sacrifice that resonates with anyone facing a long road ahead.
Advocacy Without Surrender
Beyond her own treatment, Moshiri has emerged as a vocal supporter of Blood Cancer UK’s newly launched “Here for This” campaign, which highlights the systemic barriers that prevent patients from accessing timely care and emotional support. The campaign seeks to amplify voices often silenced by a healthcare system structured around curability rather than management. By speaking publicly about her experience, she hopes to inspire others to seek help earlier and to press policymakers toward greater investment in chronic disease infrastructure. Her advocacy is not merely performative; it stems from lived experience that underscores the gap between survival rates and quality of life. When questioned about the future outlook for patients with incurable cancers, she remained candid: “We are far from a cure. But with compassionate care, dignity, and robust research funding, the focus must shift to improving lives rather than just prolonging existence.”
Why it Matters
The story of Maryam Moshiri serves as a powerful reminder that courage extends beyond the battlefield of politics or science—it also resides in the daily decision to keep working when every fibre of one’s being begs for rest. Her case underscores the urgent need for healthcare systems worldwide to develop frameworks that accommodate chronic illness within high‑pressure roles, ensuring that talent like hers does not fade beneath the weight of its own battle. In an era where media narratives often celebrate triumphs in curable diseases, the reality of incurable conditions deserves equal attention and empathy. By sharing her journey, Moshiri illuminates the human cost behind medical statistics and urges society to look beyond headlines and offer genuine support to those navigating invisible battles.
